CGC
Price
$1.34
Change
-$0.07 (-4.96%)
Updated
May 15 closing price
Capitalization
784.64M
14 days until earnings call
SCYX
Price
$0.98
Change
+$0.03 (+3.16%)
Updated
May 15 closing price
Capitalization
55.88M
94 days until earnings call
Ad is loading...

CGC vs SCYX

Header iconCGC vs SCYX Comparison
Open Charts CGC vs SCYXBanner chart's image
Canopy Growth
Price$1.34
Change-$0.07 (-4.96%)
Volume$4.8M
Capitalization784.64M
SCYNEXIS
Price$0.98
Change+$0.03 (+3.16%)
Volume$163.69K
Capitalization55.88M
CGC vs SCYX Comparison Chart
Loading...
CGC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SCYX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CGC vs. SCYX commentary
May 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGC is a Hold and SCYX is a Hold.

Ad is loading...
COMPARISON
Comparison
May 16, 2025
Stock price -- (CGC: $1.34 vs. SCYX: $0.98)
Brand notoriety: CGC: Notable vs. SCYX: Not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: CGC: 73% vs. SCYX: 157%
Market capitalization -- CGC: $784.64M vs. SCYX: $55.88M
CGC [@Pharmaceuticals: Other] is valued at $784.64M. SCYX’s [@Pharmaceuticals: Other] market capitalization is $55.88M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGC’s FA Score shows that 0 FA rating(s) are green whileSCYX’s FA Score has 0 green FA rating(s).

  • CGC’s FA Score: 0 green, 5 red.
  • SCYX’s FA Score: 0 green, 5 red.
According to our system of comparison, SCYX is a better buy in the long-term than CGC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGC’s TA Score shows that 4 TA indicator(s) are bullish while SCYX’s TA Score has 5 bullish TA indicator(s).

  • CGC’s TA Score: 4 bullish, 5 bearish.
  • SCYX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, SCYX is a better buy in the short-term than CGC.

Price Growth

CGC (@Pharmaceuticals: Other) experienced а 0.00% price change this week, while SCYX (@Pharmaceuticals: Other) price change was +2.25% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.68%. For the same industry, the average monthly price growth was +10.59%, and the average quarterly price growth was +26.70%.

Reported Earning Dates

CGC is expected to report earnings on Aug 19, 2025.

SCYX is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+0.68% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CGC($785M) has a higher market cap than SCYX($55.9M). SCYX YTD gains are higher at: -19.107 vs. CGC (-51.095). SCYX has higher annual earnings (EBITDA): 70.9M vs. CGC (-1.02B). CGC has more cash in the bank: 186M vs. SCYX (74.4M). SCYX has less debt than CGC: SCYX (15.1M) vs CGC (693M). CGC has higher revenues than SCYX: CGC (362M) vs SCYX (140M).
CGCSCYXCGC / SCYX
Capitalization785M55.9M1,404%
EBITDA-1.02B70.9M-1,442%
Gain YTD-51.095-19.107267%
P/E RatioN/A1.06-
Revenue362M140M259%
Total Cash186M74.4M250%
Total Debt693M15.1M4,589%
FUNDAMENTALS RATINGS
CGC vs SCYX: Fundamental Ratings
CGC
SCYX
OUTLOOK RATING
1..100
763
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
55
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9896
PRICE GROWTH RATING
1..100
6363
P/E GROWTH RATING
1..100
10098
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SCYX's Valuation (55) in the Pharmaceuticals Other industry is somewhat better than the same rating for CGC (92) in the Agricultural Commodities Or Milling industry. This means that SCYX’s stock grew somewhat faster than CGC’s over the last 12 months.

SCYX's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as CGC (100) in the Agricultural Commodities Or Milling industry. This means that SCYX’s stock grew similarly to CGC’s over the last 12 months.

SCYX's SMR Rating (96) in the Pharmaceuticals Other industry is in the same range as CGC (98) in the Agricultural Commodities Or Milling industry. This means that SCYX’s stock grew similarly to CGC’s over the last 12 months.

SCYX's Price Growth Rating (63) in the Pharmaceuticals Other industry is in the same range as CGC (63) in the Agricultural Commodities Or Milling industry. This means that SCYX’s stock grew similarly to CGC’s over the last 12 months.

SCYX's P/E Growth Rating (98) in the Pharmaceuticals Other industry is in the same range as CGC (100) in the Agricultural Commodities Or Milling industry. This means that SCYX’s stock grew similarly to CGC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CGCSCYX
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 5 days ago
74%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 3 days ago
79%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 3 days ago
87%
MACD
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
76%
Bearish Trend 3 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 3 days ago
79%
Advances
ODDS (%)
Bullish Trend 9 days ago
79%
Bullish Trend 23 days ago
79%
Declines
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 3 days ago
83%
View a ticker or compare two or three
Ad is loading...
CGC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SCYX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPY590.462.87
+0.49%
SPDR® S&P 500® ETF
BTC.X103744.640000205.226560
+0.20%
Bitcoin cryptocurrency
GME28.63-0.10
-0.35%
GameStop Corp
AAPL211.45-0.88
-0.41%
Apple
TSLA342.82-4.86
-1.40%
Tesla

CGC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CGC has been closely correlated with ACB. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if CGC jumps, then ACB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGC
1D Price
Change %
CGC100%
-4.96%
ACB - CGC
71%
Closely correlated
-1.59%
TLRY - CGC
63%
Loosely correlated
-0.32%
OGI - CGC
61%
Loosely correlated
+1.64%
CRON - CGC
58%
Loosely correlated
+0.97%
SCYX - CGC
33%
Poorly correlated
+3.03%
More

SCYX and

Correlation & Price change

A.I.dvisor tells us that SCYX and TXMD have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SCYX and TXMD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SCYX
1D Price
Change %
SCYX100%
+3.03%
TXMD - SCYX
31%
Poorly correlated
N/A
OGI - SCYX
30%
Poorly correlated
+1.64%
AQST - SCYX
29%
Poorly correlated
+7.21%
CRON - SCYX
26%
Poorly correlated
+0.97%
KMDA - SCYX
24%
Poorly correlated
-2.70%
More